DionyMed Brands Inc (OTCMKTS:DYMEF) And Alumina Partners Secure CAD$32 Million Investment Deal

DionyMed Brands Inc (OTCMKTS:DYMEF) And Alumina Partners Secure CAD$32 Million Investment Deal

DionyMed Brands Inc
announced a month ago that it secured an investment deal
with Alumina Partners, through which it will receive CAD$32 million to expand
its cannabis portfolio.

DionyMed will receive the CAD$32 million over a 2-year duration and this will allow the company to expand its cannabis products into new markets where it anticipates significant returns. The investment agreement dictates that DionyMed will sell some of its shares through a private placement basis and they will be sold in tranches.

Each unit will comprise of one of a subordinate voting
share, as well as half a unit of a Voting Share purchase warrant. Each warrant
will be sold at half the value of the Subordinate Voting Share market price on
the Canadian Securities Exchange. The company will accelerate the warrants
expiry date if the Subordinate Voting Shares equate to or surpass 100% of the
warrant exercise price of their 10-day volume weight average price.

The total number of Subordinate Voting Shares that Alumina
owned at the time of the purchase surpassed 9.99% of the outstanding
Subordinate Voting Shares of DionyMed. The agreement requires that five
business days should pass before the unit issuance comes to a close.
Additionally, the pricing will feature a 15% to 20% discount that will be based
on the market price.

“This Agreement provides DionyMed with additional capital to accelerate our cannabis brands distribution and delivery platform,” stated DionyMed CEO Edward Fields.

DionyMed’s current
efforts are aimed at getting a better foothold of the market

The CEO also noted that the company is on a mission to
expand its Direct-To-Consumer footprint in California by venturing into new
markets such as Los Angeles and Sacramento. The company’s goal is to make cannabis
available across the largest market.

Alumina’s managing member Adi Nahmani noted that his company
is excited to support DionyMed through its aggressive push towards expanding
its brands. He also believes that DionyMed has the operational know-how and
competitive advantages that can put it ahead of the competition. The cannabis
industry is rapidly growing and this means that companies are currently trying
to get an edge that will allow them to leverage the most out of the industry.

Published at Tue, 09 Jul 2019 12:00:31 +0000

Be the first to comment

Leave a Reply

Your email address will not be published.